Grant

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

Open

This federal SBIR grant opportunity supports US small business concerns in conducting feasibility studies through late-stage research and development to bring scientific innovations to the commercial marketplace.

See your fit

Key facts

Organiser
National Institutes of Health
Deadline
April 5, 2027
Opens
May 28, 2026
Amount
Grant
Open to
United States
Sectors
Any sector

4 details are locked

See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.

See your fit

Key questions about NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

Who can apply to NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)?

Eligible locations: United States. The company must be incorporated in United States. Other requirements: Non-domestic (non-U.S.) Entities are not eligible to apply.

When is the NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) deadline?

The NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) deadline is April 5, 2027. Applications opened on May 28, 2026.

See more grants in United States

Other programs in this category

Verified on September 28, 2026 against the official page.